Erivedge

Type: Product

Name: Erivedge

View more in our other sites:

silobreaker

89 articles

First Reported May 08 2012 - Updated May 09 2012 - 1 Documents

Curis posts profit after skin cancer drug approval

LEXINGTON, Mass. Drug developer Curis Inc. said Tuesday that it turned a first-quarter profit after federal regulators approved its skin cancer treatment Erivedge early in the period.Curis reported a profit of $2.2 million, or 3 cents per share, for ... [ Published May 08 2012 by CBS News ]

Entities: Curis Incorporated, Erivedge, Skin Cancer

More Content

sort by: Date \| Relevance
Curis posts profit after skin cancer drug approval [ Published May 08 2012 by CBS News ]

Silobreaker Premium
Product Summary
Screenshots
View a demo
Why Silobreaker Premium
Features & Tools
Free Trial

News Search
Silobreaker.com
Press and User Feedback
Advertise

Enterprise Software
Product Summary
Video Presentation

About Us
About the Company
Technology
Contact Us
Team and Background
Press Room
Silobreaker Blog
Social Media

How To Use
Silobreaker.com
RSS
API
Widgets

Legal
Terms of Use
Privacy Policy

Some image thumbnails are sourced from Freebase, licensed under CC-BY
Copyright (C) 2010 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.